| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 28.805 | 28.065 | 21.443 | 36.163 | 39.405 | 71.953 |
| Total Income - EUR | - | - | - | - | 28.805 | 28.065 | 21.443 | 36.163 | 39.602 | 72.258 |
| Total Expenses - EUR | - | - | - | - | 2.416 | 3.618 | 4.096 | 5.306 | 20.152 | 26.297 |
| Gross Profit/Loss - EUR | - | - | - | - | 26.389 | 24.446 | 17.347 | 30.857 | 19.450 | 45.961 |
| Net Profit/Loss - EUR | - | - | - | - | 25.525 | 23.674 | 16.717 | 30.001 | 19.064 | 43.844 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Adrasteia Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 3.980 | 2.780 | 1.673 | 20.026 | 18.797 |
| Current Assets | - | - | - | - | 26.405 | 20.346 | 15.613 | 29.303 | 11.789 | 45.337 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 22.656 | 17.739 | 15.564 | 28.665 | 9.194 | 43.285 |
| Cash | - | - | - | - | 3.749 | 2.607 | 49 | 639 | 2.595 | 2.052 |
| Shareholders Funds | - | - | - | - | 25.567 | 23.891 | 16.929 | 30.218 | 19.281 | 42.392 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 875 | 492 | 1.473 | 849 | 12.618 | 21.799 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Adrasteia Medical S.r.l.